# xCare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xcare

- Industry: Business Support Services
- Headquarters: Tokyo, Japan
- Website: www.xcare-medical.com
- Total disclosed funding: $0.2M
- Latest round: Series A (Jun 9, 2026)
- Investors on record: 5

## About

Founded in 2022 and located in Tokyo, Japan, xCARE provides outsourcing services and expert recruiting solutions to facilitate your market entry into Japan. The company offers practical assistance for product development and commercialization, with a focus on the medical sector, which encompasses pharmaceuticals, regenerative medicine, and medical devices. As of 2022, Masaru Fukunaga is the CEO of the company. In June 2026, xCare raised an undisclosed amount in series A funding from mint, ANRI, Chugin Capital Partners, and Kyoto University Innovation Capital. This round was part of a larger JPY 600 million equity and debt financing.

The company is developing a business matching platform for healthcare personnel that specializes in healthcare human resources, and companies can search for experts they want to hire or ask for opinions; provide consultation from research to development and launch; provide knowledge and know-how for companies by utilizing resources both inside and outside the platform; and provide healthcare business development and sales representation.

The company plans to use the June 2026 funding to enhance the platform with AI, expand its expert network, and strengthen talent and infrastructure to support growth.

## Funding rounds

- Series A, Jun 9, 2026 — ANRI, Kyoto University Innovation Capital, mint, Chugin Capital Partners
- Seed, May 19, 2022, $0.2M — Primal Capital

## Investors

- Primal Capital — Seed
- ANRI (https://capitalatlas.ai/funds/anri) — Series A
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series A
- mint (https://capitalatlas.ai/funds/mint) — Series A
- Chugin Capital Partners (https://capitalatlas.ai/funds/chugin-capital-partners) — Series A